To the extent that upregulated PDE4 activity is known to play a pivotal role in mediating the airway asthmatic phenotype, the present findings support the notion that future interventions targeted at suppressing Gβγ function may yield novel approaches to treat asthma. This evidence concerns the gene CFB and asthma.